coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Tunbridge Wells PCN, Tunbridge Wells · Health Inequalities Profile

    PCN U68970 · NHS Kent and Medway Integrated Care Board · 8 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    84,164

    Registered population

    60.1% aged 18–64

    18.8%

    Aged 65+

    ICB 19.9% · England 17.9%

    10.0%

    Ethnic minority (non-White)

    4.9% Asian · England 9.6%

    4.1%

    In IMD quintile 1

    ICB 17.1% · England 21.0%

    ~3,371

    Core20 residents (est.)

    Resident basis; registered basis ~3,402 · see page 3

    12,108

    Hypertension register

    +4.62% in 3 yrs · England +5.60%

    941

    SMI register

    72.8% of Tunbridge Wells'

    1,249

    COPD register

    Reviews -0.05% in 3 yrs

    Forecast to 2030

    13,655

    Hypertension patients, 2030

    +1,547 on today

    62.3%

    QRISK ≥20% on statins, 2030

    +3.11pp over 3 yrs

    5.7%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    55.6%
    High-risk lipid therapy and BP control lag.

    QRISK ≥ 20% lipid therapy is 55.6% (England 63.6%) and hypertension control is 64.3% (England 70.3%), which could reflect recall or escalation gaps.

    58.8%
    Asthma and COPD annual reviews trail England.

    Annual reviews reach 58.8% for asthma (England 65.7%; 2,038 unreviewed scale indicator) and 69.3% for COPD (England 76.4%), which may reflect recall gaps.

    90.0%
    SMI physical checks and diabetes control lead.

    SMI physical health checks reach 90.0% for BMI (England 82.1%) and 89.5% for BP (England 83.4%), alongside 59.4% non-frail diabetes HbA1c control.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Aged 65+ patients reach 18.8% and aged 0-17 reach 21.1%, both above England

    TUNBRIDGE WELLS PCN has a registered population of 84,164 patients. Among registered patients, 18.8% (15,821) are aged 65+, which is below Tunbridge Wells (20.2%) and NHS Kent and Medway ICB (19.9%) but above England (17.9%). Registered patients aged 0-17 represent 21.1% (17,768), compared with England (19.6%), Tunbridge Wells (21.0%), and NHS Kent and Medway ICB (20.7%). Projected population growth to 2030 (ONS) is 2.5% under an unverified projection methodology, compared with 2.3% for England, 5.3% for Tunbridge Wells, and 6.0% for NHS Kent and Medway ICB.

    Age profile

    0–1721.1%
    18–6460.1%
    65+18.8%

    65+: ICB 19.9%, England 17.9%

    Ethnicity

    White90.0%
    Asian4.9%
    Mixed2.9%
    Black1.1%
    Other1.1%

    Older people · falls rows are Tunbridge Wells local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Tunbridge Wells LA)2,5992,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)80.3%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)59.4%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Tunbridge Wells LA)1,4549819552024/25
    Falls deaths, all ages, per 100,000 (Tunbridge Wells LA)12.414.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation is 4.1% overall but spans 10.5 pp across member practices

    Average IMD decile is 7.3 (Tunbridge Wells 6.8, NHS Kent and Medway ICB 5.4, England 5.5). The Core20 registered share is 4.1% against 2.7% in Tunbridge Wells, 17.1% in the ICB and 21.0% in England. Practice shares range by 10.5 pp: Speldhurst & Greggswood Medical Group has 10.5% (992 estimated patients), whereas Rusthall Medical Practice records 0.0%. The Wells Medical Practice has 6.7% and the largest volume (1,250 estimated patients). Practice counts and resident figures (3,371 people) use different population bases.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Speldhurst &10.5% · 992 patients
    Wells Medical6.7% · 1,250 patients
    Lonsdale4.1% · 329 patients
    Grosvenor & St3.5% · 488 patients
    Kingswood2.1% · 235 patients
    St Andrews1.1% · 108 patients
    Rusthall Medical0.0% · 0 patients
    Waterfield House0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    941

    SMI register

    1.10% recorded prevalence

    519

    Learning disability register

    0.61% recorded prevalence

    25

    Care homes, 1,165 beds

    In the PCN catchment

    7.9%

    Provide unpaid care

    Tunbridge Wells, Census 2021

    The PCN records 941 patients on the severe mental illness register (1.1%) and 519 on the learning disability register (0.6%), alongside 25 care homes (1,165 beds) in its catchment. Borough estimates of unpaid carers (7.9%) and rough sleeping (1 in 2025) cannot be extrapolated to PCN registered patients.

    Severe mental illness: physical health checks

    Recorded SMI prevalence is 1.1% (941 patients). Among individual published checks, 89.5% had blood pressure recorded (England 83.4%) and 90.0% had BMI recorded (England 82.1%). Uncaptured elements mean these figures cannot confirm full physical health check completion.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    12,108

    Hypertension register

    +4.62%

    Register growth, 3 yrs

    Tunbridge Wells +5.38% · England +5.60%

    +0.45pp

    BP control, under 80

    ≤140/90 · +1.26pp aged 80+

    +1,547

    More patients by 2030

    Forecast 13,655 (15.50%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 14.2% (12,108 patients), below 14.8% in Tunbridge Wells, 16.2% in NHS Kent and Medway ICB and 15.2% in England, yielding an unadjusted register gap range of +356 to +710 patients. Recent blood pressure monitoring reaches 86.1%, trailing England (90.0%). Blood pressure treated to target is 64.3% overall and 59.7% among patients aged under 80, trailing England (70.3% and 67.8%). Slower identification and treatment control may indicate recall or titration shortfalls, unverified locally and testable via clinical audit. Lower treatment control than England leaves more diagnosed patients at cardiovascular risk, indicating that systematic recall and medication titration should be prioritised.

    Lipids and statins

    Lipid-lowering therapy reaches 55.6% for patients with QRISK ≥ 20% (England 63.6%) and 64.8% for primary prevention diabetes (England 73.2%). Adults aged 18+ receive 1,766 lipid items per 1,000, trailing England (4,100). Fewer at-risk patients receive lipid therapy than England, so recall audits should be prioritised.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 2026117,280£1.80£1.90£1.86£211,104
    Cardiovascular (all), 2025160,502£3.94£3.57£3.33£632,378

    For lipid-regulating drugs in 2026, the PCN prescribed 117,280 items at £1.80 per item, against £1.73 in Tunbridge Wells, £1.90 in NHS Kent and Medway ICB and £1.86 in England, spending £7,037 less than at England's unit cost. Unit cost is below England, so clinical teams can prioritise initiating therapy over formulary switching.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +2.45%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −1.15%

    Asthma prevalence, PCN 3-yr % change

    Asthma register prevalence is 6.1% (4,942 patients), where annual reviews reach 58.8%, trailing England (65.7%) and the ICB (60.4%), leaving about 2,000 unreviewed patients (2,038 scale indicator). Asthma prescribing for ages 5–19 is 1,109 items per 1,000 (England 1,488). COPD prevalence is 1.5% (1,249 patients), below England (1.9%), with reviews reaching 69.3% (England 76.4%, ICB 72.5%) after falling 0.1% over three years (England +2.8%). Slower review reach could reflect recall or capacity pressures, unverified locally and testable via recall audits.

    Cancer register and children's immunisation

    Cancer prevalence is 4.7% (3,975 patients), exceeding England (3.8%). Childhood immunisations achieve the 95.0% target for 12-month 6-in-1 (96.1%) and age-5 MMR1 (96.7%). However, age-5 MMR2 drops 6.9 pp to 89.8% (5.2 pp below target), and the 4-in-1 booster reaches 84.9% (10.1 pp below target). Pre-school booster attrition leaves children under-protected, consistent with recall or scheduling barriers, unverified locally and testable via audit.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months96.1%

    England 91.0%

    6-in-1 complete primary course at 24 months95.2%

    England 92.2%

    MMR dose 1 at 24 months90.9%

    England 88.3%

    MMR dose 2 at age 589.8%

    England 82.8%

    4-in-1 pre-school booster at age 584.9%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Kent and Medway ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~1,630

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Kent and Medway ICBEnglandNo usable stageStaged cancers
    Breast82.1%85.4%23%1,509
    Prostate54.4%53.2%37%1,435
    Lung29.4%33.8%21%1,109
    Bowel48.2%47.0%29%1,013
    Skin cancer87.5%87.8%23%562

    Cancer stage is not published at PCN level. In 2022, 55.6% of staged cancers in NHS Kent and Medway ICB were diagnosed at stage 1 or 2 (4,661 of 8,384 known-stage cases), slightly above England (55.3%) but 19.4 pp below the 75.0% national ambition. Known-stage completeness was 63.6% (8,384 of 13,189 registrations), trailing England (67.0%). Between 2013 and 2022, the ICB early-stage share increased by +2.2 pp. An estimated 1,627 additional early-stage diagnoses annually are required across the ICB to reach 75.0%. Across Tunbridge Wells PCN, cervical screening reached 69.7% (England 66.8%), though practice variation from 61.3% at Grosvenor & St James Medical Centre to 82.2% at Rusthall Medical Practice.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    Cancer waiting times describe wider system performance and are not published at PCN level. Maidstone and Tunbridge Wells NHS Trust met all three captured standards: 62-day referral to treatment was 2.4 pp above the 85.0% standard, 28-day faster diagnosis was 6.8 pp above the 75.0% standard, and 31-day treatment was 2.3 pp above the 96.0% standard. Across NHS Kent and Medway ICB, 62-day referral to treatment was below standard by 9.1 pp and 31-day treatment was below by 0.2 pp, while 28-day faster diagnosis was 1.8 pp above standard. Strong trust performance is consistent with prompt diagnostic turnaround, though provider.

    Pathways within standard (%)Maidstone and Tunbridge WellsKing's CollegeSussexKent and Medway ICBEngland
    28-day faster diagnosis (75%)81.7880.6874.0176.7879.32
    31-day treatment (96%)98.3596.6876.7995.8492.50
    62-day referral to treatment (85%)87.4370.1565.2075.9371.16
    Diagnostic waits over 6 weeks (%)Maidstone and Tunbridge WellsKing's CollegeSussexEngland
    MRI0.9221.225.6221.40
    CT0.5122.608.579.92
    Echocardiography2.5714.390.3928.48
    Colonoscopy19.8041.8139.3530.83
    Gastroscopy24.0335.9820.0229.02
    All 15 DM01 tests6.4219.1512.9523.14
    Community services activityKent residentsKent and Medway ICB
    Care contacts210,170254,055
    Referrals59,36068,085
    Patients with a contact60,60572,060

    Community services (residents of Kent), Jun 2026 (provisional). Community contacts are reported for borough residents, not at PCN level. In Tunbridge Wells borough, adults aged 65 and over accounted for 65.8% of all community service contacts (138,250 of 210,170 contacts) in provisional Jun 2026 data. This concentration of contacts among older residents indicates that primary care coordination with community nursing may be valuable for managing older patients.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice variation and patient experience

    In 2025/26, England's overall QOF achievement was 92.5%. Across PCN practices, overall achievement ranged from 87.4% at The Wells Medical Practice to 97.1% at St Andrews Medical Centre. Vaccination achievement spanned 49.7 pp, from 29.8% at Lonsdale Medical Centre to 79.5% at St Andrews Medical Centre, against England's 55.2%. Variations may reflect documentation or call-recall differences, unverified locally.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Rusthall Medical1040.061.3%68.0%89.9%
    Wells Medical1166.741.1%84.5%86.6%
    Grosvenor & St1063.561.6%76.6%86.4%
    Lonsdale1044.167.0%74.8%86.2%
    Kingswood Surgery1062.160.2%76.6%84.1%
    St Andrews1151.160.5%64.1%77.9%
    Waterfield House1160.053.9%74.4%76.6%
    Speldhurst &11610.553.6%73.0%68.6%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNTunbridge WellsAssetPCNTunbridge Wells
    Care homes (catchment)25 (1,165 beds)n/aSchools (catchment)74n/a
    Children's centres46Places of worship6289
    Libraries79Food banks (VCS)22
    Homelessness support (VCS)n/a1Day centres (VCS)45
    Children and young people (VCS)n/a2Carers support groups (VCS)34
    Primary schools (LA maintained)1824Primary academies57

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Hypertension and lipid escalation

    On the 12,108 hypertension register (14.2%, modelled gap +356 to +710), BP control is 64.3% (England 70.3%) and QRISK ≥ 20% lipid therapy is 55.6% (England 63.6%). For discussion: practices could run pharmacist-led recall and titration clinics for uncontrolled hypertension and untreated QRISK ≥ 20% cohorts, alongside opportunistic BP checks. Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 2

    Structured asthma review recall

    Asthma review coverage is 58.8% on the 4,942 register, behind England (65.7%) by 6.9 pp and NHS Kent and Medway ICB (60.4%) by 1.7 pp, with 2,038 unreviewed (about 2,000). Low cost, quick to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 3

    COPD review and case-finding audit

    Recorded COPD prevalence is 1.5% (1,249 patients; modelled gap +75 to +345 against Tunbridge Wells and England), while annual reviews reach 69.3% (England 76.4%, ICB 72.5%). Moderate effort to run.

    Evidence base: the copd register is the cohort for spirometry-confirmed diagnosis, annual review and inhaler technique; register size and growth set the workload those interventions must cover.

    Policy anchor: Core20PLUS5 adults: chronic respiratory disease (COPD vaccination and exacerbation reduction); Tobacco and Vapes Bill: smokefree generation.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Older cohort capacity review (p2)Aged 65+Neighbourhood health framework · NHS vaccination strategyPCN
    Dual track deprivation outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Hypertension blood pressure control review (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school booster catch-up recall (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening recall audit (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Option 1 · Hypertension and lipid escalation (p12)Hypertension register · Hypertension: QOF prevalence · Hypertension patients treated to targetCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Option 2 · Structured asthma review recall (p12)Asthma register · Asthma: QOF prevalence · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 3 · COPD review and case-finding audit (p12)COPD register · COPD: QOF prevalence · COPD patients with a review in the last 12 monthsCore20PLUS5 approach · Tobacco and Vapes BillPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15